Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM

• Status: Recruiting
• Trial end date: 2028-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Clinical study evaluating vildagliptin versus vildagliptin/metformin on NAFLD with DM.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sherief Abd-Elsalam
• Treatments: Metformin; Vildagliptin

Criteria

Inclusion Criteria:

• NAFLD and type 2 DM

Exclusion Criteria:

• Viral hepatitis.

• Child score more than 6.

• renal impairment.